Avadel Pharmaceuticals Plc (AVDL) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Avadel Pharmaceuticals Plc  (NASDAQ: AVDL)


Avadel Pharmaceuticals Plc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Avadel Pharmaceuticals Plc's ROI in the third quarter of 2025?
Avadel Pharmaceuticals Plc recorded a cumulative net loss of $0 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -0.22%.

Within the Healthcare sector 213 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2025 quarter, so far to 2578, from total ROI ranking in the second quarter of 2025 at 2795.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM 0.39 % -10 % -3.83 % 6.43 % 27.08 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 137 130 117 115 115
Return On Investment (TTM) -0.22 % -2.45 % -22.93 % -42.11 % -64.37 %
AVDL's Overall Ranking # 2578 # 2795 # 3521 # 4421 # 4162
Seq. Investment Change TTM 4.5 % 3.73 % -0.66 % -6.76 % -6.32 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 -3 -26 -49 -80

AVDL Company Profile >> Back to AVDL Roi Comparisons >> See Annual AVDL Return On Investment



Return On Investment AVDL's Ranking
Within: No.
Industry # 72
Sector # 214
Overall # 2578

Return On Investment Statistics
High Average Low
9.59 %
-53.18 %
-157.49 %
(Jun 30 2020)   (Mar 31 2023)







Financial Statements
Avadel Pharmaceuticals Plc's III. Quarter Investments $ 137 Millions AVDL's Balance sheet
Avadel Pharmaceuticals Plc's III. Quarter Income $ 0 Millions Quarterly AVDL's Income Statement
AVDL's Income by Division See AVDL's Income by Division


AVDL Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 115 77 226 296 119
Y / Y Investment Growth 50.32 % -65.97 % -23.83 % 149.61 % -23.38 %
Net Income in Millions -49 -137 -77 7 -33
Y / Y Net Income Growth - - - - -
Annual Return On Investment -42.31 % -179.06 % -34.28 % 2.37 % -28 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AVDL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AVDL's Competitors
Subscribers only: Roi for Avadel Pharmaceuticals Plc's Suppliers
Subscribers only: Return On Investment for AVDL's Customers

Other Ratios
AVDL's Roa AVDL's Inventory Turnover Ratio AVDL's Growth Rates AVDL's Dividend Statistics
AVDL's Profitability Ratios AVDL's Asset Turnover Ratio AVDL's Dividend Growth
AVDL's Roe AVDL's Valuation Ratios AVDL's Financial Strength Ratios AVDL's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-18T14:07:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.